)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Evome Medical Technologies
Evome Medical Technologies (EVMT) investor relations material
Evome Medical Technologies has been delisted
Evome Medical Technologies Q3 2024 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2024 earnings summary25 Nov, 2024
Executive summary
Generated $10.0 million in revenue for Q3 2024, with $5.8 million from core business Biodex.
Achieved $424,000 in Adjusted EBITDA, marking four out of five positive quarters under current CEO.
Launched Evome Medical Products Distribution Company to expand into broader Life Science products.
Appointed Bill Garbarini as COO to drive new product initiatives and margin improvement.
Financial highlights
Q3 2024 gross margin reached $3.6 million, with $2.4 million from Biodex.
Adjusted EBITDA for Q3 2024 was $424,000, including $0.7 million from Biodex.
Debt reduced by $1.4 million in Q3 2024, with a 24% total reduction since June 2023.
Core business Biodex saw 7% gross margin growth over the prior quarter.
Outlook and guidance
Plans to launch new Biodex-branded products, including spinal care and connected force plates, in 2025.
Finalizing production for SpaceTek Knee™ and next-gen System 5 isokinetic machine.
Management expects continued revenue growth and improved product mix with higher-margin products.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Evome Medical Technologies
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Salona Global Medical Device Corp, now known as Evome Medical Technologies Inc., is a company specializing in rehabilitative solutions and physical therapy. The company's focus encompasses a range of medical devices and services aimed at human performance enhancement and rehabilitation. Among its key products are the Biodex Rehab Product, Damar Plastics Product, Mio-Guard Product, and Simbex Services, each targeting specific needs within the medical device sector. The company is headquartered in New York, USA, and its shares are listed on the TSX.